Cite
APA Citation
Saad, E., Delaloge, S., Mavroudis, D., Perez, E., Piccart-Gebhart, M., Schneider, B., Wolmark, N., Buyse, M., & Burzykowski, T. (n.d.). evaluation of disease-free survival (DFS) as a surrogate for overall survival (OS) in the adjuvant therapy of HER2-positive early breast cancer (EBC) calls for individual-patient data (IPD). Breast, 32, S26–. http://access.bl.uk/ark:/81055/vdc_100045079310.0x00004f